Humanity’s Long Struggle
For centuries, viruses have shaped the course of human history—driving plagues, pandemics, and untold suffering. From the Bubonic Plague to COVID-19, these invisible adversaries have claimed lives, destabilized economies, and tested our resilience.
As pandemics grow more frequent, the stakes—millions of lives and billions of livelihoods—are higher than ever.
A New Era
From Reactive to Proactive
We’re ushering in a new paradigm in humanity’s fight against viruses. By leveraging the discovery of RdRp Thumb-1 and pioneering broad-spectrum antiviral therapies like MDL-001, we are shifting the narrative from reactive responses to proactive preparedness. For the first time, we have the tools to target viruses across families, addressing current threats while preparing for those yet to emerge.
We’re building therapeutics for today and the pandemics of tomorrow.
A Pan-Antiviral Revolution
Just as penicillin transformed the treatment of bacterial infections, we are leading a revolution against viral diseases. MDL-001 is designed to combat multiple RNA viruses, offering a scalable, accessible solution to global health challenges.
Providing front-line workers with the tools they need to save lives and protect communities.
We’re ushering in an era where humanity can take control of its viral future—no longer at the mercy of pandemics, but prepared to face them with science, innovation, and purpose.
Explore our pipeline
Revolutionizing Antiviral Treatment
learn more
Science
Explore the Science
Learn more about the groundbreaking discovery of RdRp Thumb-1 and the innovative science driving our mission to transform global health.
Pipeline